Biomarkers for Brain Disorders: Challenges and Opportunities
Conference - Cambridge, United Kingdom
We are pleased to announce the 2nd Wellcome Trust Scientific Conference on Biomarkers for Brain Disorders: Challenges and Opportunities. This conference will once again bring together leading neuroscientists from academia and industry involved in genomics, proteomics, diagnostics, imaging and regulatory affairs.
The discovery and validation of biomarkers in neurological and neurodegenerative diseases is an important challenge for early diagnosis of disease and for the development of therapeutics. Methodological and regulatory aspects of biomarker identification and qualification across a wide spectrum of neurodevelopmental, neurodegenerative and neuropsychiatric diseases will be discussed including, autism, Parkinson's disease, Alzheimer’s disease, multiple sclerosis and schizophrenia. There will also be a series of break-out sessions for in-depth discussion on the standardization of clinical biomarkers most likely to aid diagnosis and imaging-based studies in biomarker drug discovery. This meeting provides an opportunity for scientists from academia and the commercial sector to discuss the current ‘state of the art’ in biomarkers and will aid future investment decisions in both sectors.
(Courtesy of Møller Centre. From Wikipedia)
Biomarkers for Brain Disorders: Challenges and Opportunities
Sun, Feb 03, 2013 - Tue, Feb 05, 2013
Møller Centre, Churchill College, Cambridge, United Kingdom
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
